Target intelligence / Profile preview

Thermal neutron (n (thermal))

Target
n (thermal)
Molecular classification
Other
01

Overview

A thermal neutron is a free neutron that has been slowed down to thermal equilibrium with its environment, typically possessing a kinetic energy of approximately 0.025 eV (Barth et al., 2012). In medical science, thermal neutrons are not biological targets such as receptors or enzymes, but rather serve as the external physical trigger for Boron Neutron Capture Therapy (BNCT) (IAEA, 2001). BNCT is a binary treatment modality where a boron-10 isotope is delivered to tumor cells via specialized carriers, followed by irradiation with a thermal neutron beam (Barth et al., 2012; Sauerwein et al., 2012). When a thermal neutron is captured by a boron-10 nucleus, it undergoes a nuclear reaction producing high-energy alpha particles and lithium-7 nuclei (Sauerwein et al., 2012). These particles have a very short range in tissue (5-9 micrometers), which is approximately the diameter of a single cell, allowing for highly localized destruction of tumor cells while sparing surrounding healthy tissue (Barth et al., 2012; Moss, 2014). Consequently, the thermal neutron acts as a catalyst for localized radiotherapy rather than a traditional pharmacological ligand (IAEA, 2001). This approach is primarily investigated for the treatment of invasive tumors such as glioblastoma multiforme and recurrent head and neck cancers (Barth et al., 2012).

Other names
Slow neutronLow-energy neutron
02

Mechanism of action

Thermal neutron capture by Boron-10 isotopes, leading to the emission of high-energy alpha particles and lithium-7 nuclei that induce localized cellular damage (Barth et al., 2012; Sauerwein et al., 2012).

03

Biological functions

Cell deathOther
04

Disease associations

Cancer
05

Safety considerations

Non-specific capture by Nitrogen-14 and Hydrogen-1 in healthy tissues (IAEA, 2001)Beam contamination with fast neutrons and gamma rays (Moss, 2014)
06

Interacting drugs

Borocaptate sodium

1 more in the full profile.

07

Biomarkers

18F-boronophenylalanine (18F-BPA) PET imaging for tumor-to-normal tissue (T/N) ratio assessment (Barth et al., 2012)

Beyond the preview

Go deeper on Thermal neutron (n (thermal)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thermal neutron (n (thermal)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call